During an investigation by the reception agency on May 7, Zhenghai Biotech said that the company's active biological bone products were officially marketed in early 2024. In the first quarter, it mainly completed networking in more than 2/3 of the country's provinces and admissions work in some hospitals. In the second quarter, it will continue to steadily expand the scope of admission, and sales of related products will gradually increase.
正海生物：活性生物骨产品销售二季度以后将逐步提升
Zhenghai Biotech: Sales of active biological bone products will gradually increase after the second quarter
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.